Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities and fatigue.
This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which could accelerate its treatment potential.
Doctronic reports non-drowsy allergy medications offer effective relief without sedation; popular options include loratadine, cetirizine, and fexofenadine.
GoodRx reports that seniors should use corticosteroid nasal sprays and avoid drowsy antihistamines like Benadryl to minimize side effects.
GoodRx reports that step therapy requires patients to try lower-cost medications before coverage for prescribed treatments.
GoodRx reports many medications, like antidepressants and blood thinners, can cause hair loss.
A cannabis legalization movement that for a decade rode a wave of success has stalled amid failed ballot initiatives, rising health concerns and a frayed coalition of supporters.
Researchers are anxiously awaiting government action on rescheduling cannabis.
Kivo reports that quality control significantly drives up prescription costs by ensuring safety and compliance in the pharmaceutical industry.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.